BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

404 related articles for article (PubMed ID: 22629427)

  • 1. Fibroblast growth factor signaling potentiates VE-cadherin stability at adherens junctions by regulating SHP2.
    Hatanaka K; Lanahan AA; Murakami M; Simons M
    PLoS One; 2012; 7(5):e37600. PubMed ID: 22629427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The tyrosine phosphatase SHP2 regulates recovery of endothelial adherens junctions through control of β-catenin phosphorylation.
    Timmerman I; Hoogenboezem M; Bennett AM; Geerts D; Hordijk PL; van Buul JD
    Mol Biol Cell; 2012 Nov; 23(21):4212-25. PubMed ID: 22956765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SHP2 protects endothelial cell barrier through suppressing VE-cadherin internalization regulated by MET-ARF1.
    Zhang J; Huang J; Qi T; Huang Y; Lu Y; Zhan T; Gong H; Zhu Z; Shi Y; Zhou J; Yu L; Zhang X; Cheng H; Ke Y
    FASEB J; 2019 Jan; 33(1):1124-1137. PubMed ID: 30102570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Src-induced tyrosine phosphorylation of VE-cadherin is not sufficient to decrease barrier function of endothelial monolayers.
    Adam AP; Sharenko AL; Pumiglia K; Vincent PA
    J Biol Chem; 2010 Mar; 285(10):7045-55. PubMed ID: 20048167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SHP2 association with VE-cadherin complexes in human endothelial cells is regulated by thrombin.
    Ukropec JA; Hollinger MK; Salva SM; Woolkalis MJ
    J Biol Chem; 2000 Feb; 275(8):5983-6. PubMed ID: 10681592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resolvin D1 via prevention of ROS-mediated SHP2 inactivation protects endothelial adherens junction integrity and barrier function.
    Chattopadhyay R; Raghavan S; Rao GN
    Redox Biol; 2017 Aug; 12():438-455. PubMed ID: 28319894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of protein tyrosine phosphatase SHP2 in barrier function of pulmonary endothelium.
    Grinnell KL; Casserly B; Harrington EO
    Am J Physiol Lung Cell Mol Physiol; 2010 Mar; 298(3):L361-70. PubMed ID: 20023173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CMTM3 (CKLF-Like Marvel Transmembrane Domain 3) Mediates Angiogenesis by Regulating Cell Surface Availability of VE-Cadherin in Endothelial Adherens Junctions.
    Chrifi I; Louzao-Martinez L; Brandt M; van Dijk CGM; Burgisser P; Zhu C; Kros JM; Duncker DJ; Cheng C
    Arterioscler Thromb Vasc Biol; 2017 Jun; 37(6):1098-1114. PubMed ID: 28428220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atorvastatin enhances endothelial adherens junctions through promoting VE-PTP gene transcription and reducing VE-cadherin-Y731 phosphorylation.
    Huo Z; Kong Y; Meng M; Cao Z; Zhou Q
    Vascul Pharmacol; 2019 Jun; 117():7-14. PubMed ID: 29894844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphorylation of VE-cadherin controls endothelial phenotypes via p120-catenin coupling and Rac1 activation.
    Hatanaka K; Simons M; Murakami M
    Am J Physiol Heart Circ Physiol; 2011 Jan; 300(1):H162-72. PubMed ID: 21037229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The FGF system has a key role in regulating vascular integrity.
    Murakami M; Nguyen LT; Zhuang ZW; Moodie KL; Carmeliet P; Stan RV; Simons M
    J Clin Invest; 2008 Oct; 118(10):3355-66. PubMed ID: 18776942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PKCα activation of p120-catenin serine 879 phospho-switch disassembles VE-cadherin junctions and disrupts vascular integrity.
    Vandenbroucke St Amant E; Tauseef M; Vogel SM; Gao XP; Mehta D; Komarova YA; Malik AB
    Circ Res; 2012 Aug; 111(6):739-49. PubMed ID: 22798526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pyk2 phosphorylation of VE-PTP downstream of STIM1-induced Ca
    Soni D; Regmi SC; Wang DM; DebRoy A; Zhao YY; Vogel SM; Malik AB; Tiruppathi C
    Am J Physiol Lung Cell Mol Physiol; 2017 Jun; 312(6):L1003-L1017. PubMed ID: 28385807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel role of vascular endothelial cadherin in modulating c-Src activation and downstream signaling of vascular endothelial growth factor.
    Ha CH; Bennett AM; Jin ZG
    J Biol Chem; 2008 Mar; 283(11):7261-70. PubMed ID: 18180305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. VE-PTP stabilizes VE-cadherin junctions and the endothelial barrier via a phosphatase-independent mechanism.
    Juettner VV; Kruse K; Dan A; Vu VH; Khan Y; Le J; Leckband D; Komarova Y; Malik AB
    J Cell Biol; 2019 May; 218(5):1725-1742. PubMed ID: 30948425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dynamics of vascular endothelial-cadherin and beta-catenin localization by vascular endothelial growth factor-induced angiogenesis in human umbilical vein cells.
    Wright TJ; Leach L; Shaw PE; Jones P
    Exp Cell Res; 2002 Nov; 280(2):159-68. PubMed ID: 12413882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sirt3 Maintains Microvascular Endothelial Adherens Junction Integrity to Alleviate Sepsis-Induced Lung Inflammation by Modulating the Interaction of VE-Cadherin and
    Chen DQ; Shen MJ; Wang H; Li Y; Tang AL; Li S; Xiong MC; Guo Y; Zhang GQ
    Oxid Med Cell Longev; 2021; 2021():8978795. PubMed ID: 34630854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. eNOS-derived nitric oxide regulates endothelial barrier function through VE-cadherin and Rho GTPases.
    Di Lorenzo A; Lin MI; Murata T; Landskroner-Eiger S; Schleicher M; Kothiya M; Iwakiri Y; Yu J; Huang PL; Sessa WC
    J Cell Sci; 2013 Dec; 126(Pt 24):5541-52. PubMed ID: 24046447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phospholipase D2 restores endothelial barrier function by promoting PTPN14-mediated VE-cadherin dephosphorylation.
    Fu P; Ramchandran R; Shaaya M; Huang L; Ebenezer DL; Jiang Y; Komarova Y; Vogel SM; Malik AB; Minshall RD; Du G; Tonks NK; Natarajan V
    J Biol Chem; 2020 May; 295(22):7669-7685. PubMed ID: 32327488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. S-nitrosylation regulates VE-cadherin phosphorylation and internalization in microvascular permeability.
    Guequén A; Carrasco R; Zamorano P; Rebolledo L; Burboa P; Sarmiento J; Boric MP; Korayem A; Durán WN; Sánchez FA
    Am J Physiol Heart Circ Physiol; 2016 Apr; 310(8):H1039-44. PubMed ID: 26921435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.